Douglas A. Jabs, M.D., M.B.A.
Professor and Chair

Douglas A. Jabs, M.D., M.B.A. is Professor and Chairman of the Department of Ophthalmology at Mount Sinai School of Medicine. He previously was the Alan C. Woods Professor of Ophthalmology and Professor of Medicine at The Johns Hopkins University School of Medicine, Professor of Epidemiology at The Johns Hopkins University Bloomberg School of Public Health, and Director of the Division of Ocular Immunology at The Wilmer Eye Institute. He received his undergraduate degree from Dartmouth College and his M.D. from The Johns Hopkins University School of Medicine. His training includes an internship in Internal Medicine at the New York Hospital-Cornell Medical Center, a residency in Internal Medicine at the Johns Hopkins Hospital, a residency in Ophthalmology at The Wilmer Eye Institute, and a fellowship in Rheumatology at The Johns Hopkins Medical Institutions. In 1984, he joined the faculty at The Johns Hopkins University School of Medicine and was promoted to Professor in both Ophthalmology and Medicine in 1993. He received a Masters of Science in Business from The John Hopkins University School of Continuing Studies in 1998, and a Masters of Business Administration from The Johns Hopkins University School of Professional Studies in Business and Education in 2000. He became Chairman of Ophthalmology at the Mount Sinai School of Medicine in March 2007.

Dr. Jabs has been recipient of such honors and awards as the Research to Prevent Blindness Olga Keith Wiess Scholar Award, the Research to Prevent Blindness Lew R. Wasserman Merit Award, the Research to Prevent Blindness Senior Scientific Investigator, the American Academy of Ophthalmology Honor Award, and the Ethel Baxter Award for Excellence in Research from the Sjögren's Syndrome Foundation. He has given several named lectures and is a frequent invited speaker at national and international meetings. Dr. Jabs is a member of a number of professional societies, including the Retina Society, the Macula Society, the American Society of Retina Specialists, the American Ophthalmological Society, the International Uveitis Study Group, and the American Uveitis Society. He served as President of the American Uveitis Society for 2000-2002. He served on the National Eye Institute’s Visual Sciences A Study Section from 1994 to 1998 and currently is on the National Eye Institute Intramural Program Data and Safety Monitoring Committee. Dr. Jabs serves on the editorial boards of the American Journal of Ophthalmology, Retina - The Journal of Retinal and Vitreous Diseases, and Ocular Inflammation and Immunity, and from 2002 To 2007 was the executive editor for uveitis of the American Journal of Ophthalmology.

He has held funding from the National Eye Institute since 1986, including both clinical and bench research activities. He is the chairman of the Studies of Ocular Complications of AIDS Research Group, a clinical trials and epidemiology program, which has been in existence since 1988, has conducted five multicenter, randomized clinical trials on the treatment of cytomegalovirus retinitis and now chairs an ongoing multicenter, prospective, cohort study of patients with AIDS for ocular complications and visual outcomes. He also is chairman of the Multicenter Uveitis Steroid Treatment Trial, which is a multicenter, randomized clinical trial on the treatment of severe uveitis. His other research interests include the immunopathogenesis of autoimmune ocular disease, the epidemiology, molecular biology and clinical consequences of resistant cytomegalovirus among patients being treated for cytomegalovirus retinitis, and the treatment of uveitis. He has authored or coauthored over 195 publications and 44 book chapters. His areas of expertise include the treatment of uveitis and other ophthalmic inflammatory disorders, the ocular complications of autoimmune disease, immune deficiency and immune suppression, and cytomegalovirus retinitis.